Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays - PubMed (original) (raw)
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays
S D Der et al. Proc Natl Acad Sci U S A. 1998.
Abstract
The pleiotropic activities of interferons (IFNs) are mediated primarily through the transcriptional regulation of many downstream effector genes. The mRNA profiles from IFN-alpha, -beta, or -gamma treatments of the human fibrosarcoma cell line, HT1080, were determined by using oligonucleotide arrays with probe sets corresponding to more than 6,800 human genes. Among these were transcripts for known IFN-stimulated genes (ISGs), the expression of which were consistent with previous studies in which the particular ISG was characterized as responsive to either Type I (alpha, beta) or Type II (gamma) IFNs, or both. Importantly, many novel IFN-stimulated genes were identified that were diverse in their known biological functions. For instance, several novel ISGs were identified that are implicated in apoptosis (including RAP46/Bag-1, phospholipid scramblase, and hypoxia inducible factor-1alpha). Furthermore, several IFN-repressed genes also were identified. These results demonstrate the usefulness of oligonucleotide arrays in monitoring mammalian gene expression on a broad and unprecedented scale. In particular, these findings provide insights into the basic mechanisms of IFN actions and ultimately may contribute to better therapeutic uses for IFNs.
Figures
Figure 1
Genes up-regulated by IFNs. The probe sets from hybridized oligonucleotide arrays corresponding to the indicated IFN-induced genes are represented. 9–27 is an example of a gene that is regulated by all IFNs. IRF-1 is preferentially induced by IFN-γ. 2–5A-Synthetase (1.8 kb mRNA; 2–5AS) is induced selectively by IFN-α and -β, but not IFN-γ. HIF-1α is selectively induced by IFN-β. Perfect-match oligonucleotides are tiled across the upper rows of each boxed probe set while corresponding single-base mismatch oligonucleotides are tiled across the lower rows.
Similar articles
- Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2.
Leaman DW, Chawla-Sarkar M, Jacobs B, Vyas K, Sun Y, Ozdemir A, Yi T, Williams BR, Borden EC. Leaman DW, et al. J Interferon Cytokine Res. 2003 Dec;23(12):745-56. doi: 10.1089/107999003772084860. J Interferon Cytokine Res. 2003. PMID: 14769151 - Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.
Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R. Metz P, et al. Hepatology. 2012 Dec;56(6):2082-93. doi: 10.1002/hep.25908. Epub 2012 Oct 14. Hepatology. 2012. PMID: 22711689 - Transcription factors in interferon signaling.
David M. David M. Pharmacol Ther. 1995 Feb;65(2):149-61. doi: 10.1016/0163-7258(94)00050-d. Pharmacol Ther. 1995. PMID: 7540766 Review. - Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis.
Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC. Chawla-Sarkar M, et al. Apoptosis. 2003 Jun;8(3):237-49. doi: 10.1023/a:1023668705040. Apoptosis. 2003. PMID: 12766484 Review.
Cited by
- Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.
Hubackova S, Krejcikova K, Bartek J, Hodny Z. Hubackova S, et al. J Biol Chem. 2012 Aug 3;287(32):26702-14. doi: 10.1074/jbc.M111.316869. Epub 2012 Jun 18. J Biol Chem. 2012. PMID: 22711534 Free PMC article. - Sensitivity of African swine fever virus to type I interferon is linked to genes within multigene families 360 and 505.
Golding JP, Goatley L, Goodbourn S, Dixon LK, Taylor G, Netherton CL. Golding JP, et al. Virology. 2016 Jun;493:154-61. doi: 10.1016/j.virol.2016.03.019. Epub 2016 Apr 1. Virology. 2016. PMID: 27043071 Free PMC article. - Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease.
Negi CK, Khan S, Dirven H, Bajard L, Bláha L. Negi CK, et al. Int J Mol Sci. 2021 Apr 20;22(8):4282. doi: 10.3390/ijms22084282. Int J Mol Sci. 2021. PMID: 33924165 Free PMC article. Review. - Twenty-five years of type I interferon-based treatment: a critical analysis of its therapeutic use.
Antonelli G, Scagnolari C, Moschella F, Proietti E. Antonelli G, et al. Cytokine Growth Factor Rev. 2015 Apr;26(2):121-31. doi: 10.1016/j.cytogfr.2014.12.006. Epub 2014 Dec 30. Cytokine Growth Factor Rev. 2015. PMID: 25578520 Free PMC article. Review. - Enhanced inhibition of foot-and-mouth disease virus by combinations of porcine interferon-α and antiviral agents.
Kim SM, Park JH, Lee KN, Kim SK, Ko YJ, Lee HS, Cho IS. Kim SM, et al. Antiviral Res. 2012 Nov;96(2):213-20. doi: 10.1016/j.antiviral.2012.09.009. Epub 2012 Sep 21. Antiviral Res. 2012. PMID: 23000495 Free PMC article.
References
- Stark G R, Kerr I M, Williams B R G, Silverman R H, Schreiber R D. Annu Rev Biochem. 1998;67:227–264. - PubMed
- Darnell J E, Jr, Kerr I M, Stark G R. Science. 1994;264:1415–1421. - PubMed
- Nguyen H, Hiscott J, Pitha P M. Cytokine Growth Factor Rev. 1997;8:293–312. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI034039/AI/NIAID NIH HHS/United States
- R01 CA044059/CA/NCI NIH HHS/United States
- P01 CA062220/CA/NCI NIH HHS/United States
- P01 HG0132/HG/NHGRI NIH HHS/United States
- AI34039/AI/NIAID NIH HHS/United States
- CA44059/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources